Casiopeinas IIgly and IIIia induce apoptosis in medulloblastoma cells

Carmen Mejia1, Lena Ruiz-Azuara

  • 1Departamento de Neurobiología Molecular y Celular, Instituto de Neurobiología, Boulevard Universitario 3001, Querétaro, Mexico. maria.c.mejia@uv.es

Insights

Casiopeinas, copper-based compounds, show promise in treating childhood medulloblastoma by inducing apoptosis. These molecules exhibit tumoral specificity and trigger programmed cell death in cancer cells.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Medulloblastoma is a common childhood central nervous system tumor.
  • Casiopeinas are copper (2+) complexes with potential anti-cancer properties.
  • The anti-cancer mechanism of Casiopeinas, particularly in medulloblastoma, requires further elucidation.

Purpose of the Study:

  • To investigate the efficacy of Casiopeinas in inducing apoptosis in medulloblastoma cells.
  • To explore the potential of Casiopeinas as a targeted therapy for medulloblastoma.

Main Methods:

  • Medulloblastoma cell survival was assessed using the MTT assay.
  • Apoptosis was identified through nuclear condensation, mitochondrial membrane potential disruption, and cytoskeleton analysis.
  • Cells were treated with Casiopeinas IIgly and IIIia.

Main Results:

  • Casiopeina treatment significantly increased apoptotic features in medulloblastoma cells compared to controls.
  • Specific Casiopeina compounds (IIgly and IIIia) demonstrated potent induction of apoptosis.
  • Evidence of nuclear condensation, mitochondrial dysfunction, and cytoskeleton disruption was observed post-treatment.

Conclusions:

  • Casiopeinas IIgly and IIIia are effective in inducing apoptosis in medulloblastoma cells.
  • These compounds represent a promising therapeutic strategy for childhood medulloblastoma.
  • Further research into Casiopeinas' mechanism of action is warranted for clinical application.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.